Chronic Heart Failure Epidemiology Forecast 2025-2034

According to the Journal of Cardiac Failure, approximately 6.7 million Americans over 20 years of age have heart failure, and the prevalence is expected to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Chronic heart failure is a progressive condition where weakened heart muscles reduce blood circulation, causing fatigue, breathlessness and requiring long-term management through medications, lifestyle changes, and continuous monitoring. The chronic heart failure epidemiology forecast report will provide a comprehensive analysis of the disease's prevalence, incidence trends, and patient demographics across key regions.

Chronic Heart Failure Epidemiology Forecast Report Coverage

Expert Market Research's “Chronic Heart Failure Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of chronic heart failure. It projects the future incidence and prevalence rates of chronic heart failure cases across various populations. The study covers age, gender, and type as major determinants of the chronic heart failure population. The report highlights patterns in the prevalence of chronic heart failure over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on chronic heart failure epidemiology in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Chronic Heart Failure Understanding: Disease Overview

Chronic heart failure is a long-term condition that occurs when the heart cannot effectively pump blood to meet the body's metabolic demands. Numerous structural or functional cardiac conditions, such as coronary artery disease, hypertension, and cardiomyopathy, can cause chronic heart failure. A buildup of fluid in the lungs, belly, or extremities can result from chronic heart failure, which can affect the left, right, or both sides of the heart. Fatigue, dyspnea, ankle or leg edema, and decreased physical stamina are typical complaints. The illness has a substantial influence on a person's everyday life and general well-being and tends to get worse over time.

Chronic Heart Failure Epidemiology Perspective

The chronic heart failure epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for chronic heart failure epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic heart failure and their trends. The chronic heart failure detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the European Society of Cardiology, approximately 64 million individuals are living with heart failure.
• In the United States, heart failure contributed to over 425,000 deaths in 2021, accounting for nearly 45% of all cardiovascular-related deaths.
• The United Kingdom has an estimated heart failure prevalence of around 1.7% among the adult population.
• Germany reports one of the highest heart failures prevalence rates in Europe, reflecting its aging population and high cardiovascular risk.

Gender-Based Chronic Heart Failure Epidemiology Insights

The epidemiology of chronic heart failure is strongly influenced by gender. According to studies, the yearly incidence is higher in men (0.3%) than in women (0.2%) between the ages of 50 and 59. Heart failure with decreased ejection fraction is more common in men, whereas, women experience greater hospitalizations even if their survival rates are higher.

Age-Based Chronic Heart Failure Epidemiology Insights

Age plays a crucial role in the epidemiology of chronic heart failure. The prevalence of chronic heart failure rises with age as 1% in individuals aged 18-44, 3.6% in those aged 45-54, and 24.2% in those aged 75 and older. While older adults experience higher mortality, younger adults are increasingly affected, with chronic heart failure cases in those under 50 doubling from 3% in 1995 to 6% in 2012. In the United States, approximately 6.7 million adults aged 20 and older are living with chronic heart failure, and projections suggest this will rise to 8.7 million by 2030.

Country-wise Chronic Heart Failure Epidemiology Segment

The chronic heart failure epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Chronic heart failure is a significant global health challenge, with varying epidemiological patterns across different countries. The prevalence and incidence of chronic heart failure are influenced by factors such as population demographics, lifestyle, healthcare access, and advancements in treatment. According to an article published by the National Center for Biotechnology Information (NCBI), the prevalence of chronic heart failure in India is estimated to range from 1.3 million to 4.6 million individuals, with an annual incidence between 491,600 and 1.8 million cases. A more recent study suggests that chronic heart failure affects approximately 8 to 10 million people, constituting about 1% of the total population.

Chronic Heart Failure: Treatment Overview

First-line therapies for chronic heart failure include beta-blockers, diuretics, and ACE inhibitors or angiotensin receptor blockers (ARBs), intended to control fluid overload and lessen cardiac workload. SGLT2 inhibitors and aldosterone antagonists are utilized to stop the progression of the condition. In certain situations, cardiac resynchronization therapy (CRT) or implanted cardioverter-defibrillators (ICDs) are advised. Left ventricular assist devices (LVADs) or heart transplants may be considered in extreme circumstances. In order to effectively manage chronic heart failure, lifestyle changes such as dietary adjustments and physical activity are also essential.

Key Questions Answered

• What are the key findings of chronic heart failure epidemiology in the 8 major markets?
• What will be the total number of patients with chronic heart failure across the 8 major markets during the forecast period?
• What was the country-wise chronic heart failure epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of chronic heart failure patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of chronic heart failure during the forecast period of 2025-2034?
• What are the currently available treatments in the chronic heart failure market?
• What are the disease risks, signs, symptoms, and unmet needs of chronic heart failure?

Scope of the Chronic Heart Failure Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic heart failure based on several factors.
• Chronic Heart Failure Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The chronic heart failure report helps to identify the patient population and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

This product will be delivered within 3-5 business days.